Abstract
The National Institute for Clinical Excellence (NICE) uses economic evaluation as the means to assess new treatments: this is a process unfamiliar to many clinicians. High technology treatments used in paediatric intensive care are expensive and have been subject to economic evaluation. A systematic review of the literature was performed for economic evaluations of treatments used for critically ill children with cardio-pulmonary failure. Of 3604 potentially eligible studies identified, there were 16 cost minimisation studies addressing applicable treatments but only 9 cost effectiveness or cost utility evaluations were found and subjected to review. Three studies dealt with the UK trial of extracorporeal membrane oxygenation (ECMO) for neonates, two studies addressed ECMO and transplantation in paediatric cardiac patients, two studies evaluated ECMO in mixed paediatric respiratory failure populations and two studies assessed the cost effectiveness of inhaled nitric oxide in neonatal respiratory failure. There are inherent problems in performing economic studies in this paediatric field. However, economic evaluation with adherence to guidelines is recommended. Given recent NHS reforms, it is clear that economic evaluation will remain an important focus of debate and is likely to become more prevalent rather than less.
Keywords: Economic evaluation, paediatrics, critical care
Current Pediatric Reviews
Title: Economic Evaluation in Paediatric Practice: Examples from Cardiac Critical Care
Volume: 4 Issue: 4
Author(s): Katherine L. Brown
Affiliation:
Keywords: Economic evaluation, paediatrics, critical care
Abstract: The National Institute for Clinical Excellence (NICE) uses economic evaluation as the means to assess new treatments: this is a process unfamiliar to many clinicians. High technology treatments used in paediatric intensive care are expensive and have been subject to economic evaluation. A systematic review of the literature was performed for economic evaluations of treatments used for critically ill children with cardio-pulmonary failure. Of 3604 potentially eligible studies identified, there were 16 cost minimisation studies addressing applicable treatments but only 9 cost effectiveness or cost utility evaluations were found and subjected to review. Three studies dealt with the UK trial of extracorporeal membrane oxygenation (ECMO) for neonates, two studies addressed ECMO and transplantation in paediatric cardiac patients, two studies evaluated ECMO in mixed paediatric respiratory failure populations and two studies assessed the cost effectiveness of inhaled nitric oxide in neonatal respiratory failure. There are inherent problems in performing economic studies in this paediatric field. However, economic evaluation with adherence to guidelines is recommended. Given recent NHS reforms, it is clear that economic evaluation will remain an important focus of debate and is likely to become more prevalent rather than less.
Export Options
About this article
Cite this article as:
Brown L. Katherine, Economic Evaluation in Paediatric Practice: Examples from Cardiac Critical Care, Current Pediatric Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339608787407708
DOI https://dx.doi.org/10.2174/157339608787407708 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical and Pharmacological Aspects of Immunoprophylaxis for Respiratory Syncytial Virus Infection in High-Risk Infants
Current Drug Metabolism Future Targets in Endothelial Biology: Endothelial Cell to Mesenchymal Transition
Current Drug Targets Abnormalities of hsa-mir-16 and hsa-mir-124 Affect Mitochondrial Function and Fatty Acid Metabolism in Tetralogy of Fallot
Combinatorial Chemistry & High Throughput Screening Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design A PHACES Syndrome Unmasked by Propranolol Interruption in a Tetralogy of Fallot Patient: Case Report and Extensive Review on New Indications of Beta Blockers
Current Medicinal Chemistry Variations and Abnormalities of Major Thoracic Vascular Structures
Current Medical Imaging Repair of Dilated Aortic Root and Sinotubular Junction Using a Stabilizer Ring
Recent Patents on Cardiovascular Drug Discovery Submaximal Field Walking Tests Applied in the Cardiopulmonary Assessment in Congenital Heart Diseases: A Systematic Review
Current Pediatric Reviews Mechanical Ventilation Following Cardiac Surgery in Children
Current Respiratory Medicine Reviews Structural Chromosome Abnormalities Associated with Obesity: Report of Four New Subjects and Review of Literature
Current Genomics Editorial: Pharmacological Therapy to Prevent Sudden Cardiac Death: Indications and Limitations in the Era of Devices
Mini-Reviews in Medicinal Chemistry Normal Ventricular Functional Reference Parameters on Magnetic Resonance Imaging in Healthy Children
Current Medical Imaging Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives
Current Cardiology Reviews Does Pharmacological Therapy Still Play a Role in Preventing Sudden Death in Surgically Treated Tetralogy of Fallot?
Mini-Reviews in Medicinal Chemistry Genome-wide Analysis of Myelodysplastic Syndromes
Current Pharmaceutical Design Medical and Dental Implications of Down Syndrome: A Review Part 1: General and Craniofacial Characteristic
Applied Clinical Research, Clinical Trials and Regulatory Affairs Cardiac Role of the Transcription Factor NF-κB
Cardiovascular & Hematological Disorders-Drug Targets Secondary Stroke Prevention in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Vascular Disease Prevention (Discontinued) Roles of Connexins in Atherosclerosis and Ischemia-Reperfusion Injury
Current Pharmaceutical Biotechnology Pharmacological manipulation of peripheral vascular resistance in special clinical situations after pediatric cardiac surgery
Current Vascular Pharmacology